Omnicell Inc
NASDAQ:OMCL

Watchlist Manager
Omnicell Inc Logo
Omnicell Inc
NASDAQ:OMCL
Watchlist
Price: 36.69 USD 1.41% Market Closed
Market Cap: $1.6B

Gross Margin

42.5%
Current
Declining
by 0.8%
vs 3-y average of 43.2%

Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.

Gross Margin
42.5%
=
Gross Profit
$503.4m
/
Revenue
$1.2B

Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.

Gross Margin
42.5%
=
Gross Profit
$503.4m
/
Revenue
$1.2B

Peer Comparison

Country Company Market Cap Gross
Margin
US
Omnicell Inc
NASDAQ:OMCL
1.6B USD
Loading...
US
Cerner Corp
LSE:0R00
31.3B USD
Loading...
US
Veeva Systems Inc
NYSE:VEEV
28.6B USD
Loading...
AU
Pro Medicus Ltd
ASX:PME
12.3B AUD
Loading...
JP
M3 Inc
TSE:2413
1.1T JPY
Loading...
US
Doximity Inc
NYSE:DOCS
4.7B USD
Loading...
SE
Sectra AB
STO:SECT B
35.5B SEK
Loading...
US
Waystar Holding Corp
NASDAQ:WAY
3.9B USD
Loading...
CN
Winning Health Technology Group Co Ltd
SZSE:300253
25.2B CNY
Loading...
IN
Inventurus Knowledge Solutions Ltd
NSE:IKS
281.4B INR
Loading...
US
Vocera Communications Inc
F:V00
2.4B EUR
Loading...

Market Distribution

In line with most companies in the United States of America
Percentile
49th
Based on 12 729 companies
49th percentile
42.5%
Low
-24 813% — 28.9%
Typical Range
28.9% — 60.5%
High
60.5% — 10 905 714.3%
Distribution Statistics
the United States of America
Min -24 813%
30th Percentile 28.9%
Median 43%
70th Percentile 60.5%
Max 10 905 714.3%

Omnicell Inc
Glance View

Omnicell Inc. stands at the intersection of healthcare and technology, sculpting the landscape of medication management systems with its innovative spirit. Founded in 1992, Omnicell has evolved from a small enterprise into a leading provider of automated solutions for medication and supply dispensing, inventory management, and analytics. The company’s core offering, its automated dispensing systems, reshapes how hospitals, pharmacies, and healthcare providers manage medications. By utilizing cutting-edge technology, Omnicell improves efficiency, reduces medication errors, and cuts down on healthcare costs. These systems are embedded in the workflow of healthcare facilities, ensuring that medication management becomes seamless, thus elevating patient safety and clinical outcomes. Revenue streams flow robustly from both product sales and associated services. Omnicell garners income by selling its advanced hardware systems, which include everything from pharmacy carousels to medication robotic systems, and supplements these sales with software solutions that offer predictive analytics and inventory optimization. Beyond the initial sale, a significant part of their business model includes recurring revenue through service contracts, software updates, and customer support. This dual approach not only ensures a steady cash flow but also strengthens customer relationships by consistently providing value over time. As the healthcare industry increasingly leans on technology for streamlined operations and cost management, Omnicell’s strategic positioning allows it to capitalize on the demand for sophisticated medication management solutions.

OMCL Intrinsic Value
34.82 USD
Overvaluation 5%
Intrinsic Value
Price
What is Gross Margin?
Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.
How is Gross Margin calculated?

Gross Margin is calculated by dividing the Gross Profit by the Revenue.

Gross Margin
42.5%
=
Gross Profit
$503.4m
/
Revenue
$1.2B
What is Omnicell Inc's current Gross Margin?

The current Gross Margin for Omnicell Inc is 42.5%, which is below its 3-year median of 43.2%.

How has Gross Margin changed over time?

Over the last 3 years, Omnicell Inc’s Gross Margin has decreased from 46.1% to 42.5%. During this period, it reached a low of 41.4% on Sep 30, 2024 and a high of 46.1% on Dec 31, 2022.

Back to Top